Chemcrux Enterprises share price & results
- Jun 2026
- Jun 2026
Vadodara-based (Ankleshwar-plant) manufacturer of chemical intermediates used in API, dyes and pigments manufacturing
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 21.9 | +31.0% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 12.9 | +3.4 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 1.4 | +136.2% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
| Return on equity | 5.48 | −1.8 pts | Trailing twelve months | TTM to Jun 2026 | Adjusted profit attributable to owners ÷ average owners’ equity. |
| Free cash flow margin | 10.84 | +11.8 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | 24.03 | +26.0 pts | Trailing twelve months | TTM to Jun 2026 | Revenue change against the same period one year earlier. |
Price
Performance −28.9% 1Y
1Y: ₹111.05 on 24 Oct 2025 → ₹78.97. High ₹141.9 (31 Oct 2025), low ₹65.8 (30 Mar 2026).
- Previous close
- ₹77.52
- Market cap
- ₹118 Cr
- 52-week range
- ₹65.8 – ₹141.9
- One year
- −28.21%
- Price to earnings (TTM to Jun 2026)
- 28.43×
- Return on equity (TTM to Jun 2026)
- 5.48%
Overview
- Symbol
- NSE:CHEMCRUX
- Sector
- Chemicals
- Industry
- Commodities
- Exchange
- NSE
- Currency
- INR
What Chemcrux Enterprises Limited does
Based on the company's own presentations, annual report and earnings calls.
Chemcrux Enterprises makes chemical intermediates that feed into the manufacture of Active Pharmaceutical Ingredients (API), dyes and pigments, a business it has run for over four decades from its Ankleshwar (Gujarat) facility. It maintains an in-house R&D facility at the same GIDC site to develop and refine its process chemistry. In FY25 the company converted its erstwhile joint venture, Kalichem Private Limited, into a wholly owned subsidiary.
Segments
- API intermediates
- Dyes intermediates
- Pigments intermediates
- Manufacturing facility
- 1 (GIDC, Ankleshwar, Gujarat)
- Wholly owned subsidiary
- Kalichem Private Limited (converted from JV, Feb 2025)
- R&D facility
- In-house, located at GIDC, Ankleshwar, Gujarat
- Quality/EHS certifications
- ISO 9001, ISO 14001, ISO 50001 certified
- FY25 energy consumption
- 3,995 MWh (plus 61,629.6 units from captive DG set)
- Years in operation
- 40+ years (since 1983)
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 5 fiscal years held (Mar 2022 to Mar 2026).
Financials
What the filings say
Net profit, year on year: +136% (quarter to jun 2026 against jun 2025).
| Line item | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 18 | 19 | 16 | 17 | 19 | 23 | 24 | 22 |
| Expenses | 15 | 17 | 14 | 15 | 17 | 20 | 21 | 19 |
| Operating profit | 2 | 3 | 2 | 2 | 2 | 3 | 4 | 3 |
| Operating margin | 13.3% | 13.8% | 12.2% | 9.5% | 9.0% | 14.6% | 14.9% | 12.9% |
| Other income | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 0 |
| Interest | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Profit before tax | 2 | 2 | 1 | 1 | 1 | 3 | 3 | 2 |
| Tax rate | 26.3% | 25.8% | 35.6% | 19.2% | 18.2% | 22.7% | 29.2% | 25.9% |
| Net profit | 1 | 1 | 0 | 1 | 1 | 2 | 2 | 1 |
| EPS (₹ per share) | 0.78 | 0.90 | 0.32 | 0.39 | 0.54 | 1.40 | 1.34 | 0.93 |
| Line item | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 78 | 70 | 83 |
| Expenses | 65 | 61 | 72 |
| Operating profit | 13 | 9 | 10 |
| Other income | 1 | 2 | 3 |
| Interest | 1 | 2 | 2 |
| Depreciation | 2 | 3 | 4 |
| Profit before tax | 11 | 6 | 7 |
| Net profit | 8 | 4 | 5 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 15 | 15 | 15 | 15 | 15 | 15 |
| Reserves | 40 | 52 | 57 | 61 | 60 | 65 |
| Borrowings | 9 | 14 | 26 | 27 | 37 | 22 |
| Other liabilities | 19 | 12 | 11 | 9 | 12 | 15 |
| Total liabilities | 83 | 93 | 110 | 112 | 124 | 118 |
| Fixed assets | 24 | 33 | 33 | 58 | 76 | 56 |
| Capital work in progress | 0 | 0 | 21 | 2 | 4 | 4 |
| Investments | 7 | 17 | 20 | 20 | 17 | 16 |
| Other assets | 52 | 43 | 36 | 33 | 28 | 41 |
| Total assets | 83 | 93 | 110 | 112 | 124 | 118 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Cash from operations | 9 | 15 | 16 | 7 | 12 |
| Cash from investing | -3 | -20 | -26 | -8 | -2 |
| Cash from financing | 3 | 1 | 8 | -3 | -8 |
| Net cash flow | 9 | -5 | -2 | -4 | 1 |
| Free cash flow | 5 | 4 | -7 | -1 | 7 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 23 | 72 | 52 | 71 | 63 | 85 |
| Inventory days | 137 | 92 | 125 | 100 | 127 | 60 |
| Days payable | 16 | 93 | 71 | 71 | 53 | 89 |
| Cash conversion cycle | 144 | 72 | 105 | 100 | 138 | 56 |
| Working capital days | 68 | 38 | 67 | 55 | 50 | 31 |
| Return on capital employed | 31.6% | 37.6% | 27.8% | 13.5% | 7.1% | 7.8% |
| Dividend payout | 11.1% | 19.9% | 20.6% | 17.6% | 35.4% | 27.2% |
What the price assumes
Growth trapTo justify its price of ₹79, this stock must grow earnings at 15% every year for 7 years. Our analysis caps realistic growth at ~-20%. At that growth it is worth ₹12 — downside of 85%.
- Growth the price implies
- 14.8% a year
- for 7 years, fading to 4%
- It has actually compounded at
- -19.6% a year
- net profit, FY24–FY26 · EPS -19.8%
- The gap
- 0.3 pp
- -85% downside if it only repeats history
Ownership
Who owns it
Promoters hold 72.92% as of Jun 2026.
- Promoters 72.92%
- Public 27.08%
Who is on the register
Named in the Jun 2026 filing
Every holder of Chemcrux Enterprises Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| 36.46% | unchanged | |
| 36.46% | unchanged | |
| 1.48% | unchanged | |
| 1.01% | −0.48 pp |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for Chemcrux Enterprises Limited
Free account: one company. Everything above stays public.
Write why you follow Chemcrux Enterprises Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Chemicals companies
Learn to analyse Chemcrux Enterprises Limited
Guides on how to read this kind of business and the numbers that matter.







